Clinical trial
Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold
NCT02539966 is registered in ClinicalTrials.gov with REVA Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold
- Lead sponsor
- REVA Medical, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2015
- Completion date
- September 30, 2024
- Enrollment
- 272 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.